Pasar al contenido principal

PREDICCION DE VULNERABILIDADES TERAPEUTICAS EN CANCER POR MEDIO DE LA DESCOMPOSICION DE TRANSCRIPTOMAS DE LONGITUD COMPLETA

BIO2017-85364-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POMPEU FABRA CCT

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

ISOTOPE: ISOform-guided prediction of epiTOPEs in cancer

  • Trincado Alonso, Juan Luis, 1987-
  • Reixachs i Solé, Marina
  • Pérez-Granado, Judith
  • Fugmann, Tim
  • Sanz, Ferran
  • Yokota, Jun
  • Eyras Jiménez, Eduardo
Immunotherapies provide effective treatments for previously untreatable tumors and identifying tumor-specific epitopes can help elucidate the molecular determinants of therapy response. Here, we describe a pipeline, ISOTOPE (ISOform-guided prediction of epiTOPEs In Cancer), for the comprehensive identification of tumor-specific splicing-derived epitopes. Using RNA sequencing and mass spectrometry for MHC-I associated proteins, ISOTOPE identified neoepitopes from tumor-specific splicing events that are potentially presented by MHC-I complexes. Analysis of multiple samples indicates that splicing alterations may affect the production of self-epitopes and generate more candidate neoepitopes than somatic mutations. Although there was no difference in the number of splicing-derived neoepitopes between responders and non-responders to immune therapy, higher MHC-I binding affinity was associated with a positive response. Our analyses highlight the diversity of the immunogenic impacts of tumor-specific splicing alterations and the importance of studying splicing alterations to fully characterize tumors in the context of immunotherapies. ISOTOPE is available at https://github.com/comprna/ISOTOPE., Funding: This work was supported by the Spanish Government and European Regional Development Fund (FEDER) with grant BIO2017-85364-R (F.S., E.E.), by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya) with grants SGR2017-1020 (E.E) and 2017 SGR 00519 (F.S), by the Instituto de Salud Carlos III (ISCIII and FEDER) with grants FI18/00034 (J.P-G) and PT17/0009/0014 (F.S), and by the AEI with CEX2018-000782-M (F.S). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB) supported by ISCIII and FEDER (PT17/0009/0014). The DCEXS is a ‘Unidad de Excelencia María de Maeztu’ supported by the AEI (CEX2018-000782-M)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1

  • Closa, Adrià
  • Reixachs i Solé, Marina
  • Fuentes-Fayos, Antonio C.
  • Hayer, Katharina E.
  • Melero, Juan L.
  • Adriaanse, Fabienne R.S.
  • Bos, Romy S.
  • Torres-Diz, Manuel
  • Hunger, Stephen P.
  • Roberts, Kathryn G.
  • Mullighan, Charles G.
  • Stam, Ronald W.
  • Thomas-Tikhonenko, Andrei
  • Castaño, Justo P.
  • Luque, Raul M.
  • Eyras Jiménez, Eduardo
A significant proportion of infant B-cell acute lymphoblastic leukemia (B-ALL) patients remains with a dismal prognosis due to yet undetermined mechanisms. We performed a comprehensive multicohort analysis of gene expression, gene fusions, and RNA splicing alterations to uncover molecular signatures potentially linked to the observed poor outcome. We identified 87 fusions with significant allele frequency across patients and shared functional impacts, suggesting common mechanisms across fusions. We further identified a gene expression signature that predicts high risk independently of the gene fusion background and includes the upregulation of the splicing factor SRRM1. Experiments in B-ALL cell lines provided further evidence for the role of SRRM1 on cell survival, proliferation, and invasion. Supplementary analysis revealed that SRRM1 potentially modulates splicing events associated with poor outcomes through protein-protein interactions with other splicing factors. Our findings reveal a potential convergent mechanism of aberrant RNA processing that sustains a malignant phenotype independently of the underlying gene fusion and that could potentially complement current clinical strategies in infant B-ALL., Spanish Ministerio de Ciencia, Innovación y Universidades [BIO2017-85364-R]; EMBL Australia (to A.C., M.R-S., J.L.M., E.E.); National Institutes of Health [U01 CA232563 to A.T-T.]; M.T-D. acknowledges support from the Ellen Weisberg Fund: Advancing Breakthroughs in Pediatric Cancer. This work was further supported by the Spanish Ministry of Science and Innovation [MICINN, PID2019-105201RB-I00 to J.P.C.]; Junta de Andalucía [BIO-0139]; Universidad de Córdoba-FEDER [UCO-202099901918904 to J.P.C.]; GETNE2019 Research grant (to J.P.C.); CIBERobn Fisiopatología de la Obesidad y Nutrición (CIBER is an initiative of Instituto de Salud Carlos III, co-funded by the European Union: ERDF/ESF, ‘Investing in your future’).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

RATTLE: reference-free reconstruction and quantification of transcriptomes from Nanopore sequencing

  • Rubia, Ivan de la
  • Srivastava, Akanksha
  • Xue, Wenjing
  • Indi, Joel A.
  • Carbonell-Sala, Sílvia
  • Lagarde, Julien
  • Albà Soler, Mar
  • Eyras Jiménez, Eduardo
Nanopore sequencing enables the efficient and unbiased measurement of transcriptomes. Current methods for transcript identification and quantification rely on mapping reads to a reference genome, which precludes the study of species with a partial or missing reference or the identification of disease-specific transcripts not readily identifiable from a reference. We present RATTLE, a tool to perform reference-free reconstruction and quantification of transcripts using only Nanopore reads. Using simulated data and experimental data from isoform spike-ins, human tissues, and cell lines, we show that RATTLE accurately determines transcript sequences and their abundances, and shows good scalability with the number of transcripts., This work was funded by the Spanish Agencia Estatal de Investigación with grants BFU2015-65235-P (to M.M. Alba), by the Spanish Ministerio de Ciencia, Innovación y Universidades with grants BIO2017-85364-R (to E. Eyras), PGC2018-094091-B-I00 (to M.M. Alba), and PRE2018-083413 (to I. de la Rubia), by the Catalan Government (AGAUR) with grant SGR2017-1020 (to M.M. Alba), and by the Australian Research Council (ARC) with grants DP210102385 and DP220101352 (to E. Eyras).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Ribosome profiling at isoform level reveals evolutionary conserved impacts of differential splicing on the proteome

  • Reixachs i Solé, Marina
  • Ruiz Orera, Jorge, 1988-
  • Albà Soler, Mar
  • Eyras Jiménez, Eduardo
The differential production of transcript isoforms from gene loci is a key cellular mechanism. Yet, its impact in protein production remains an open question. Here, we describe ORQAS (ORF quantification pipeline for alternative splicing), a pipeline for the translation quantification of individual transcript isoforms using ribosome-protected mRNA fragments (ribosome profiling). We find evidence of translation for 40-50% of the expressed isoforms in human and mouse, with 53% of the expressed genes having more than one translated isoform in human, and 33% in mouse. Differential splicing analysis revealed that about 40% of the splicing changes at RNA level are concordant with changes in translation. Furthermore, orthologous cassette exons between human and mouse preserve the directionality of the change, and are enriched in microexons in a comparison between glia and glioma. ORQAS leverages ribosome profiling to uncover a widespread and evolutionarily conserved impact of differential splicing on translation, particularly of microexon-containing isoforms., We acknowledge funding from the Spanish Government and FEDER with grants BFU2015-65235-P, BIO2017-85364-R, and MDM-2014-0370, and by Catalan Government (AGAUR) with grant SGR2017-1020. MR-S had funding from an FI grant from the Catalan Government with reference 2018FI_B1_00126 for part of this work.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions

  • Trincado Alonso, Juan Luis, 1987-
  • Entizne, Juan Carlos
  • Hysenaj, Gerald
  • Singh, Babita, 1986-
  • Skalic, Miha, 1990-
  • Elliott, David, 1947-
  • Eyras Jiménez, Eduardo
Despite the many approaches to study differential splicing from RNA-seq, many challenges remain unsolved, including computing capacity and sequencing depth requirements. Here we present SUPPA2, a new method that addresses these challenges, and enables streamlined analysis across multiple conditions taking into account biological variability. Using experimental and simulated data, we show that SUPPA2 achieves higher accuracy compared to other methods, especially at low sequencing depth and short read length. We use SUPPA2 to identify novel Transformer2-regulated exons, novel microexons induced during differentiation of bipolar neurons, and novel intron retention events during erythroblast differentiation., This work was supported by the MINECO and FEDER with grants BIO2014-52566-R and BIO2017-85364-R, by AGAUR with grants SGR2014-1121 and SGR2017-1020, by BBSRC (BB/P006612/1), and by Breast Cancer Now (2014NovPR355). GH is a BBSRC-funded PhD student.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Uncovering the impacts of alternative splicing on the proteome with current omics techniques

  • Reixachs i Solé, Marina
  • Eyras Jiménez, Eduardo
The high-throughput sequencing of cellular RNAs has underscored a broad effect of isoform diversification through alternative splicing on the transcriptome. Moreover, the differential production of transcript isoforms from gene loci has been recognized as a critical mechanism in cell differentiation, organismal development, and disease. Yet, the extent of the impact of alternative splicing on protein production and cellular function remains a matter of debate. Multiple experimental and computational approaches have been developed in recent years to address this question. These studies have unveiled how molecular changes at different steps in the RNA processing pathway can lead to differences in protein production and have functional effects. New and emerging experimental technologies open exciting new opportunities to develop new methods to fully establish the connection between messenger RNA expression and protein production and to further investigate how RNA variation impacts the proteome and cell function. This article is categorized under: RNA Processing > Splicing Regulation/Alternative Splicing Translation > Regulation RNA Evolution and Genomics > Computational Analyses of RNA., Ministerio de Ciencia e Innovación. Grant Number: BIO2017-85364-R
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

ReorientExpress: reference-free orientation of nanopore cDNA reads with deep learning

  • Ruiz Reche, Angel
  • Srivastava, Akanksha
  • Indi, Joel A.
  • de la Rubia, Ivan
  • Eyras Jiménez, Eduardo
We describe ReorientExpress, a method to perform reference-free orientation of transcriptomic long sequencing reads. ReorientExpress uses deep learning to correctly predict the orientation of the majority of reads, and in particular when trained on a closely related species or in combination with read clustering. ReorientExpress enables long-read transcriptomics in non-model organisms and samples without a genome reference without using additional technologies and is available at https://github.com/comprna/reorientexpress., Part of this work was funded by the Spanish Government and FEDER with grants BIO2017-85364-R and MDM-2014-0370 and by Catalan Government (AGAUR) with grant SGR2017-1020. JI was supported by a PhD grant from FCT (Fundação para a Ciência e a Tecnologia) Portugal. IdlR had funding from an FPI grant from the Spanish Government (PRE2018-083413).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity

  • Bueno, Clara
  • Velasco-Hernández, Talia
  • Gutiérrez-Agüera, Francisco
  • Zanetti, Samanta Romina
  • Baroni, Matteo L.
  • Sánchez-Martínez, Diego
  • Molina, Oscar
  • Closa, Adria
  • Agraz-Doblas, Antonio
  • Marín, Pedro
  • Eyras, Eduardo
  • Varela, Ignacio
  • Menéndez, Pablo
© The Author(s) 2019., Chimeric antigen receptors (CARs) have undoubtedly revolutionized immunotherapy, especially in the B-cell acute lymphoblastic leukemia (ALL) arena where over 80% of complete remissions are observed in refractory/relapsed (R/R) B-cell ALL patients treated with CD19-directed CAR T-cells (CARTs) [1]. However, despite holding an unprecedented promise, several issues still have to be resolved before CARTs can be expanded to novel targets and/or malignancies or even provided as first-line treatment in Bcell ALL [2]. For instance, toxicities such as cytokine release syndrome and immune escape mechanisms including loss of the antigen under CART-mediated pressure remain major concerns, urging further research on the mechanisms underlying CARTs cytotoxicity., This work has been supported by the European Research Council (CoG-2014-646903, PoC-2018-811220) to PM, the Spanish Ministry of Economy and Competitiveness (MINECO, SAF-SAF2016-80481-R, BIO2017-85364-R) to PM and EE, the Generalitat de Catalunya (SGR330, SGR102 and PERIS) to PM and EE, the Spanish Association against cancer (AECC-CI-2015) to CB, and the Health Institute Carlos III (ISCIII/FEDER, PI14-01191) to CB. PM also acknowledges financial support from the Obra Social La Caixa-Fundaciò Josep Carreras. SRZ and TV are supported by a Marie Curie fellowships. OM is supported by the Catalan Government through a Beatriu de Pinos fellowship. MB is supported by MINECO through a PhD scholarship. PM is an investigator of the Spanish Cell Therapy cooperative network (TERCEL)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

ISOTOPE: ISOform-guided prediction of epiTOPEs in cancer

  • Trincado Alonso, Juan Luis, 1987-
  • Reixachs i Solé, Marina
  • Pérez-Granado, Judith
  • Fugmann, Tim
  • Sanz, Ferran
  • Yokota, Jun
  • Eyras Jiménez, Eduardo
Immunotherapies provide effective treatments for previously untreatable tumors and identifying tumor-specific epitopes can help elucidate the molecular determinants of therapy response. Here, we describe a pipeline, ISOTOPE (ISOform-guided prediction of epiTOPEs In Cancer), for the comprehensive identification of tumor-specific splicing-derived epitopes. Using RNA sequencing and mass spectrometry for MHC-I associated proteins, ISOTOPE identified neoepitopes from tumor-specific splicing events that are potentially presented by MHC-I complexes. Analysis of multiple samples indicates that splicing alterations may affect the production of self-epitopes and generate more candidate neoepitopes than somatic mutations. Although there was no difference in the number of splicing-derived neoepitopes between responders and non-responders to immune therapy, higher MHC-I binding affinity was associated with a positive response. Our analyses highlight the diversity of the immunogenic impacts of tumor-specific splicing alterations and the importance of studying splicing alterations to fully characterize tumors in the context of immunotherapies. ISOTOPE is available at https://github.com/comprna/ISOTOPE., Funding: This work was supported by the Spanish Government and European Regional Development Fund (FEDER) with grant BIO2017-85364-R (F.S., E.E.), by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya) with grants SGR2017-1020 (E.E) and 2017 SGR 00519 (F.S), by the Instituto de Salud Carlos III (ISCIII and FEDER) with grants FI18/00034 (J.P-G) and PT17/0009/0014 (F.S), and by the AEI with CEX2018-000782-M (F.S). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB) supported by ISCIII and FEDER (PT17/0009/0014). The DCEXS is a ‘Unidad de Excelencia María de Maeztu’ supported by the AEI (CEX2018-000782-M)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

ReorientExpress: reference-free orientation of nanopore cDNA reads with deep learning

  • Ruiz Reche, Angel
  • Srivastava, Akanksha
  • Indi, Joel A.
  • de la Rubia, Ivan
  • Eyras Jiménez, Eduardo
We describe ReorientExpress, a method to perform reference-free orientation of transcriptomic long sequencing reads. ReorientExpress uses deep learning to correctly predict the orientation of the majority of reads, and in particular when trained on a closely related species or in combination with read clustering. ReorientExpress enables long-read transcriptomics in non-model organisms and samples without a genome reference without using additional technologies and is available at https://github.com/comprna/reorientexpress., Part of this work was funded by the Spanish Government and FEDER with grants BIO2017-85364-R and MDM-2014-0370 and by Catalan Government (AGAUR) with grant SGR2017-1020. JI was supported by a PhD grant from FCT (Fundação para a Ciência e a Tecnologia) Portugal. IdlR had funding from an FPI grant from the Spanish Government (PRE2018-083413).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Uncovering the impacts of alternative splicing on the proteome with current omics techniques

  • Reixachs i Solé, Marina
  • Eyras Jiménez, Eduardo
The high-throughput sequencing of cellular RNAs has underscored a broad effect of isoform diversification through alternative splicing on the transcriptome. Moreover, the differential production of transcript isoforms from gene loci has been recognized as a critical mechanism in cell differentiation, organismal development, and disease. Yet, the extent of the impact of alternative splicing on protein production and cellular function remains a matter of debate. Multiple experimental and computational approaches have been developed in recent years to address this question. These studies have unveiled how molecular changes at different steps in the RNA processing pathway can lead to differences in protein production and have functional effects. New and emerging experimental technologies open exciting new opportunities to develop new methods to fully establish the connection between messenger RNA expression and protein production and to further investigate how RNA variation impacts the proteome and cell function. This article is categorized under: RNA Processing > Splicing Regulation/Alternative Splicing Translation > Regulation RNA Evolution and Genomics > Computational Analyses of RNA., Ministerio de Ciencia e Innovación. Grant Number: BIO2017-85364-R
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1

  • Closa, Adrià
  • Reixachs i Solé, Marina
  • Fuentes-Fayos, Antonio C.
  • Hayer, Katharina E.
  • Melero, Juan L.
  • Adriaanse, Fabienne R.S.
  • Bos, Romy S.
  • Torres-Diz, Manuel
  • Hunger, Stephen P.
  • Roberts, Kathryn G.
  • Mullighan, Charles G.
  • Stam, Ronald W.
  • Thomas-Tikhonenko, Andrei
  • Castaño, Justo P.
  • Luque, Raul M.
  • Eyras Jiménez, Eduardo
A significant proportion of infant B-cell acute lymphoblastic leukemia (B-ALL) patients remains with a dismal prognosis due to yet undetermined mechanisms. We performed a comprehensive multicohort analysis of gene expression, gene fusions, and RNA splicing alterations to uncover molecular signatures potentially linked to the observed poor outcome. We identified 87 fusions with significant allele frequency across patients and shared functional impacts, suggesting common mechanisms across fusions. We further identified a gene expression signature that predicts high risk independently of the gene fusion background and includes the upregulation of the splicing factor SRRM1. Experiments in B-ALL cell lines provided further evidence for the role of SRRM1 on cell survival, proliferation, and invasion. Supplementary analysis revealed that SRRM1 potentially modulates splicing events associated with poor outcomes through protein-protein interactions with other splicing factors. Our findings reveal a potential convergent mechanism of aberrant RNA processing that sustains a malignant phenotype independently of the underlying gene fusion and that could potentially complement current clinical strategies in infant B-ALL., Spanish Ministerio de Ciencia, Innovación y Universidades [BIO2017-85364-R]; EMBL Australia (to A.C., M.R-S., J.L.M., E.E.); National Institutes of Health [U01 CA232563 to A.T-T.]; M.T-D. acknowledges support from the Ellen Weisberg Fund: Advancing Breakthroughs in Pediatric Cancer. This work was further supported by the Spanish Ministry of Science and Innovation [MICINN, PID2019-105201RB-I00 to J.P.C.]; Junta de Andalucía [BIO-0139]; Universidad de Córdoba-FEDER [UCO-202099901918904 to J.P.C.]; GETNE2019 Research grant (to J.P.C.); CIBERobn Fisiopatología de la Obesidad y Nutrición (CIBER is an initiative of Instituto de Salud Carlos III, co-funded by the European Union: ERDF/ESF, ‘Investing in your future’).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

RATTLE: reference-free reconstruction and quantification of transcriptomes from Nanopore sequencing

  • Rubia, Ivan de la
  • Srivastava, Akanksha
  • Xue, Wenjing
  • Indi, Joel A.
  • Carbonell-Sala, Sílvia
  • Lagarde, Julien
  • Albà Soler, Mar
  • Eyras Jiménez, Eduardo
Nanopore sequencing enables the efficient and unbiased measurement of transcriptomes. Current methods for transcript identification and quantification rely on mapping reads to a reference genome, which precludes the study of species with a partial or missing reference or the identification of disease-specific transcripts not readily identifiable from a reference. We present RATTLE, a tool to perform reference-free reconstruction and quantification of transcripts using only Nanopore reads. Using simulated data and experimental data from isoform spike-ins, human tissues, and cell lines, we show that RATTLE accurately determines transcript sequences and their abundances, and shows good scalability with the number of transcripts., This work was funded by the Spanish Agencia Estatal de Investigación with grants BFU2015-65235-P (to M.M. Alba), by the Spanish Ministerio de Ciencia, Innovación y Universidades with grants BIO2017-85364-R (to E. Eyras), PGC2018-094091-B-I00 (to M.M. Alba), and PRE2018-083413 (to I. de la Rubia), by the Catalan Government (AGAUR) with grant SGR2017-1020 (to M.M. Alba), and by the Australian Research Council (ARC) with grants DP210102385 and DP220101352 (to E. Eyras).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions

  • Trincado Alonso, Juan Luis, 1987-
  • Entizne, Juan Carlos
  • Hysenaj, Gerald
  • Singh, Babita, 1986-
  • Skalic, Miha, 1990-
  • Elliott, David, 1947-
  • Eyras Jiménez, Eduardo
Despite the many approaches to study differential splicing from RNA-seq, many challenges remain unsolved, including computing capacity and sequencing depth requirements. Here we present SUPPA2, a new method that addresses these challenges, and enables streamlined analysis across multiple conditions taking into account biological variability. Using experimental and simulated data, we show that SUPPA2 achieves higher accuracy compared to other methods, especially at low sequencing depth and short read length. We use SUPPA2 to identify novel Transformer2-regulated exons, novel microexons induced during differentiation of bipolar neurons, and novel intron retention events during erythroblast differentiation., This work was supported by the MINECO and FEDER with grants BIO2014-52566-R and BIO2017-85364-R, by AGAUR with grants SGR2014-1121 and SGR2017-1020, by BBSRC (BB/P006612/1), and by Breast Cancer Now (2014NovPR355). GH is a BBSRC-funded PhD student.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Ribosome profiling at isoform level reveals evolutionary conserved impacts of differential splicing on the proteome

  • Reixachs i Solé, Marina
  • Ruiz Orera, Jorge, 1988-
  • Albà Soler, Mar
  • Eyras Jiménez, Eduardo
The differential production of transcript isoforms from gene loci is a key cellular mechanism. Yet, its impact in protein production remains an open question. Here, we describe ORQAS (ORF quantification pipeline for alternative splicing), a pipeline for the translation quantification of individual transcript isoforms using ribosome-protected mRNA fragments (ribosome profiling). We find evidence of translation for 40-50% of the expressed isoforms in human and mouse, with 53% of the expressed genes having more than one translated isoform in human, and 33% in mouse. Differential splicing analysis revealed that about 40% of the splicing changes at RNA level are concordant with changes in translation. Furthermore, orthologous cassette exons between human and mouse preserve the directionality of the change, and are enriched in microexons in a comparison between glia and glioma. ORQAS leverages ribosome profiling to uncover a widespread and evolutionarily conserved impact of differential splicing on translation, particularly of microexon-containing isoforms., We acknowledge funding from the Spanish Government and FEDER with grants BFU2015-65235-P, BIO2017-85364-R, and MDM-2014-0370, and by Catalan Government (AGAUR) with grant SGR2017-1020. MR-S had funding from an FI grant from the Catalan Government with reference 2018FI_B1_00126 for part of this work.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

ISOTOPE, ISOform-guided prediction of epiTOPEs in cancer

  • Trincado Alonso, Juan Luis, 1987-|||0000-0001-5363-3774
  • Reixachs Solé, Marina|||0000-0001-9446-8082
  • Pérez Granado, Judith|||0000-0002-4098-3000
  • Fugmann, Tim|||0000-0002-7447-7480
  • Sanz, Ferran|||0000-0002-7534-7661
  • Yokota, Jun|||0000-0001-6010-6294
  • Eyras, Eduardo|||0000-0003-0793-6218
Immunotherapies provide effective treatments for previously untreatable tumors and identifying tumor-specific epitopes can help elucidate the molecular determinants of therapy response. Here, we describe a pipeline, ISOTOPE (ISOform-guided prediction of epiTOPEs In Cancer), for the comprehensive identification of tumor-specific splicing-derived epitopes. Using RNA sequencing and mass spectrometry for MHC-I associated proteins, ISOTOPE identified neoepitopes from tumor-specific splicing events that are potentially presented by MHC-I complexes. Analysis of multiple samples indicates that splicing alterations may affect the production of self-epitopes and generate more candidate neoepitopes than somatic mutations. Although there was no difference in the number of splicing-derived neoepitopes between responders and non-responders to immune therapy, higher MHC-I binding affinity was associated with a positive response. Our analyses highlight the diversity of the immunogenic impacts of tumor-specific splicing alterations and the importance of studying splicing alterations to fully characterize tumors in the context of immunotherapies. ISOTOPE is available at https://github.com/comprna/ISOTOPE.